The chronic airway infections with Pseudomonas aeruginosa in people with cystic fibrosis (CF) are treated with aerosolized antibiotics, oral fluoroquinolones, and/or intravenous combination therapy with aminoglycosides and ␤-lactam antibiotics. An international strain collection of 361 P. aeruginosa isolates from 258 CF patients seen at 30 CF clinics was examined for mutations in 17 antimicrobial susceptibility and resistance loci that had been identified as hot spots of mutation by genome sequencing of serial isolates from a single CF clinic. Combinatorial amplicon sequencing of pooled PCR products identified 1,112 sequence variants that were not present in the genomes of representative strains of the 20 most common clones of the global P. aeruginosa population. A high frequency of singular coding variants was seen in spuE, mexA, gyrA, rpoB, fusA1, mexZ, mexY, oprD, ampD, parR, parS, and envZ (amgS), reflecting the pressure upon P. aeruginosa in lungs of CF patients to generate novel protein variants. The proportion of nonneutral amino acid exchanges was high. Of the 17 loci, mexA, mexZ, and pagL were most frequently affected by independent stop mutations. Private and de novo mutations seem to play a pivotal role in the response of P. aeruginosa populations to the antimicrobial load and the individual CF host. C ystic fibrosis (CF) is a severe autosomal recessive trait that is caused by mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR) (1). CFTR dysfunction affects many organs, but lung disease is responsible for the vast majority of morbidity and mortality in people with CF. The basic defect in CF predisposes to viral and bacterial airway infections (2). The most prevalent airway pathogen in adolescents and adults with CF is Pseudomonas aeruginosa (3, 4). The chronic airway colonization with P. aeruginosa has been associated with a rapid decline in lung function, heightened lung inflammation, and worse prognosis (1).
C
ystic fibrosis (CF) is a severe autosomal recessive trait that is caused by mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR) (1) . CFTR dysfunction affects many organs, but lung disease is responsible for the vast majority of morbidity and mortality in people with CF. The basic defect in CF predisposes to viral and bacterial airway infections (2) . The most prevalent airway pathogen in adolescents and adults with CF is Pseudomonas aeruginosa (3, 4) . The chronic airway colonization with P. aeruginosa has been associated with a rapid decline in lung function, heightened lung inflammation, and worse prognosis (1) .
Antipseudomonal chemotherapy in CF comprises intravenous combination therapy with ␤-lactam antibiotics and aminoglycosides, oral fluoroquinolones, immunomodulatory treatment with azithromycin and aerosolized antibiotics such as tobramycin, aztreonam, or colistin (4) (5) (6) (7) (8) . The high antimicrobial pressure exerted on the microorganism, which can persist and diversify in the patient's airways for decades, drives the emergence of drug resistance phenotypes (9, 10) . Typical targets are elements of replication, transcription, and translation, the cell wall, and transport and its regulation (9) (10) (11) .
During ongoing studies on the long-term microevolution of P. aeruginosa in lungs of 12 CF patients, we have identified 17 loci to be repetitively hit by mutations. These loci are known from the literature to be associated with the emergence of drug resistance in P. aeruginosa (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . Hence, we became interested to know if and to what extent the global P. aeruginosa population in lungs of patients (CF lungs) carries mutations in these genes. A large collection of more than 350 independent CF isolates collected from 30 CF centers (23) was investigated by amplicon sequencing of the spectrum of mutations. Single nucleotide substitutions (SNPs) were queried as to whether they represent already-known polymorphisms in the P. aeruginosa pangenome (24) . Close to 60% of the more than 1,900 detected SNPs were not present in the pangenome of the 20 most frequent P. aeruginosa clones (23, 24) . The large proportion of more than 300 singular yet-undescribed mutations indicates strong diversifying selection in these loci that promotes an advantage to P. aeruginosa to persist in CF lungs and to withstand the strong and continuous antimicrobial pressure.
MATERIALS AND METHODS
Strains. The analyzed P. aeruginosa strains were selected from the Hannover strain collection (23) . The 361 isolates (see Table S1 in the supplemental material) had been retrieved from respiratory tract specimens of 258 people with cystic fibrosis (CF) regularly seen at 30 CF centers in 12 European countries. Strains were stored at Ϫ80°C in cryotubes filled with 85% (vol/vol) Luria-Bertani (LB) broth-15% glycerol.
Isolation of genomic DNA. An aliquot of the frozen stock was inoculated in 5 ml LB and grown overnight at 37°C. Genomic DNA was isolated by extraction with phenol and chloroform-isoamyl alcohol (24:1, vol/vol) as described by Dale and Greenaway (25) . Stock solutions of 10 ng DNA/l were made up after measurement of DNA concentration by spectrophotometry (E 260 -E 320 ).
Gene loci selected for amplicon sequencing. To be selected for sequencing, the loci had to fulfill two criteria. First, they belong to the 136 most frequently mutated genes in an ongoing whole-genome sequencing project with serial isolates from people with CF seen at the CF clinic Hannover. Second, they are known from the literature to be associated with susceptibility and/or resistance to antimicrobial drugs (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) .
Primer design and PCR. Sequences of the 17 target loci were extracted from the Pseudomonas database (26) . Oligonucleotide primer pairs were designed with the Web-based "Primer search" (http://genomics2.mh -hannover.de/primer) or "Primer 3" (http://primer3.ut.ee) and subsequent manual curation to cover the targets by one to three overlapping PCR products. Primer pairs were iteratively optimized by systematic modification of PCR conditions. First, the hybridization temperature and reaction time were varied. If a PCR product could not be reliably generated, variable amounts of MgCl 2 , dimethyl sulfoxide (DMSO), and/or betaine were added to the reaction mixture. Yield and absence of byproducts were controlled by agarose gel electrophoresis of PCR products of at least two unrelated DNA templates. In total, 20 different PCR conditions had to be tested to optimize the 25 primer pairs listed in Table S2 in the supplemental material.
The 25 PCR products were amplified separately from each DNA template by 96-well PCR. Subsequently, the PCR products of each isolate were combined in one mixture, and then 21 pools, each consisting of the PCR mixtures of 49 isolates, were assembled. The 25 combined PCR products of each isolate were introduced into three separate pools so that singular sequence variants could be identified by a unique triple-heptamer code, i.e., a cube of 7 levels by 7 rows by 7 columns. The combinatorial analysis was applied to 21 ϫ 49/3 ϭ 343 of the 361 isolates. The PCR products of the remaining 18 isolates, which had been collected during the first year of CF airways colonization, were sequenced separately strain by strain.
DNA library preparation. Amounts of 0.1 to 1 g of DNA were sheared in a Covaris S2 system for 14 min. Fragment libraries were prepared at the E120 scale according to the protocols provided by Thermo Life Technologies (LT) for SOLiD 5500XL instruments. These standard protocols generate a bias for GC-rich sequences, as the ligation of the adaptors becomes inefficient for DNA fragments containing more than 65% GC (27) , which are common for P. aeruginosa with its average genomic GC content of 67%. To compensate for this constraint, we modified the ligation step of the standard protocol (LT). The dA tailing reaction was performed in 1/4 of the standard volume with Stratec Taq polymerase instead of the LT dA tailing enzyme (9 l of DNA, 2. Sequencing. The binding of the fragment library to beads was performed according to the manufacturer's protocols (EZBead System [LT]; E120 scale, P2 postenrichment of 17%). The sequencing of the 21 amplicon pools was performed on a SOLiD 5500XL system (LT) with a 75-bp read length and implemented Exact call chemistry (LT). The accuracy of sequencing by the instrument was determined independently to be 99.943%; i.e., a mean of 57 single nucleotide errors are estimated per 100,000 bp of raw sequence (unpublished data).
Sequence analysis. Raw color-space sequencing data were processed to remove SOLiD barcode sequences, trimmed, and freed from low-quality reads. Trimmed SOLiD reads were aligned to the PA14 reference genome (NC_008463.1) by using the program NovoalignCS (Novocraft, Selangor, Malaysia) and the parameters -F CSFASTAnQV -r Random -c 16 -o SAM to create sam files. bam files were created from the sam files with picard-tools 1.68.
SNPs were called in a three-step process using samtools (28) and ReadExplorer (24) from the bam files. At first "samtools mpileup" was performed with the options -g and -B (generate BCF output [genotype likelihoods]; disable BAQ computation), followed by a filter step using "bcftools view" with the options -c, -v, -g, and -P (SNP calling [force -e]; output potential variant sites only [force -c]; call genotypes at variant sites [force -c]; type of prior, full, cond2, flat [full]). The last step was the command "vcfutils.pl varFilter" to create the full SNP list. Of the curated vcf file, the only entries considered were those with a coverage of more than 49, a consistent ratio of sequence variants of 0.3 to 0.7 on both strands, a minimal frequency of the alternative nucleotide in 0.8% of reads covering the SNP, and a minimal detection rate of two on each strand. SNP statistics were analyzed with the tool SnpEff 3 (29) .
Sequence variants were classified as synonymous SNPn (S), nonsynonymous SNP (N), or stop mutations. N/S ratios were calculated for each gene. The frequency of sequence variants in the target loci was compared with those found in the pangenome of the 20 most common P. aeruginosa clones (24). Fisher's exact test was applied to search for significant differences between the N/S ratios of the pangenome and CF strain panel.
Amino acid changes were grouped and analyzed according to the Dayhoff similarity index matrix, which describes the frequencies of amino acid substitutions between closely related proteins (30) . The potential impact of amino acid exchanges on the structure and/or function of the protein was examined in the context of its epidemiology, mutant characteristics, and/or three-dimensional structure, if available from the literature.
RESULTS AND DISCUSSION
Study design. P. aeruginosa isolates were scanned for sequence variants in 17 antimicrobial susceptibility loci that, according to ongoing studies in serial isolates from the Hannover CF clinic, should present hot spots of mutations during colonization of CF airways. The 361 P. aeruginosa strains had been collected from 258 CF patients seen at 30 CF clinics located in 12 European countries (see Table S1 in the supplemental material).
The sequences of the 17 target loci were separately amplified from genomic DNA of each strain by multiwell PCR. All PCR products generated from the DNA of one strain were allocated to three predefined pools, each containing 21 mixtures of PCR products made up of 49 strains each. The combinatorial procedure ensured that unique sequence variants could be assigned to the strain by its three-digit identifier of 7 by 7 by 7 coordinates. However, the overall high number of detected SNPs precluded any assignment if the very same SNP occurred in two or more strains. The 21 49-strain pools were then subjected to amplicon sequencing. The obtained sequences of the CF strain panel were compared with those of the PA14 reference genome and the 20 most common clone types (24) in order to identify those sequence variants of the CF data set which had already been detected in other habitats and thus are not specific for the niche of the CF airway.
SNP statistics. The 17 loci cover a concatenated sequence of 26,787 bp. The sequencing of the PCR-amplified DNAs of the CF strain panel revealed 1,908 different sequence variants (SNPs) (see Table S3 in the supplemental material) compared to the PA14 reference genome; i.e., nucleotide substitutions occurred at least once at 7.1% of the sites (Table 1) . A portion consisting of 796 SNPs (41.7% of total) had already been observed in the P. aeruginosa pangenome of the 20 most common clones in the P. aeruginosa population (24) . The average sequence diversity of the concatenated 17 loci between an individual CF isolate and the PA14 reference was determined to be 0.81%, which fits with the global sequence diversity of the core genome of 0.85% between the PAO1 and PA14 reference genomes (24) .
SNPs that were either present or absent in the pangenome of the 20 most common clones differed in their fractions of synonymous (S) and nonsynonymous (N) SNPs. Nonsynonymous SNPs present in the pangenome were less frequent among SNPs (N/S ϭ 0.13; P ϭ 2.5 ϫ 10 Ϫ5 by Fisher's exact test) than expected from the N/S ratio of 0.23 derived from whole-genome sequence comparisons (27) , whereas nonsynonymous SNPs were overrepresented among the SNPs not known from the pangenome analysis (N/S ϭ 0.58; P ϭ 2.1 ϫ 10 Ϫ21 ). These data indicate that changes in the coding sequences of targets of antimicrobials are normally counterselected because these genes are probably essential for P. aeruginosa. On the other hand, in the CF lung, where P. aeruginosa is exposed to host defense and regular antipseudomonal chemotherapy, amino acid sequence variants emerge and are retained at significantly higher rates than in other habitats. The higher frequency of coding variants among CF isolates was even more pronounced in the panel of singular SNPs (N/S ϭ 1.0; P ϭ 2.9 ϫ 10 Ϫ18 ) (Fig. 1) , reflecting the selective pressure upon the bacteria in the CF lungs to generate novel protein variants of the antimicrobial targets. Of the 17 analyzed loci, the N/S ratio was significantly elevated among the ampD and mexZ variants and among the singular SNPs for spuE, mexA, gyrA, rpoB, fusA1, mexZ, mexY, oprD, ampD, parR, parS, and envZ (amgS) (Fig. 2) . Figure 3 shows the corresponding normalized frequencies of sequence variants in the analyzed loci. The largest sequence diversity was observed for oprD and mexZ, where mexZ harbored a higher proportion of habitat-associated de novo mutations, in contrast to the porin gene oprD, which is one of the most polymorphic genes in the ubiquitous P. aeruginosa population (31) . No preponderance of any amino acid change was seen in the strain panel (data not shown). The frequency distribution of amino acid substitutions was governed not by the general index of perturbation as qualified by the Dayhoff score but by the impact of the mutation on the structure and function of the individual protein. Table S4 in the supplemental material lists the 509 nonsynonymous substitutions that were detected in the P. aeruginosa CF isolates. As differentiated by normal and bold fonts in Table S4 , 91 SNPs (17.9%) are present and 418 (82.1%) are absent in the pangenome reference. When we scanned the 17 loci for SNPs in P. aeruginosa isolates from plants, soil, and aquatic habitats (26) , all but one of the 45 identified nonsynonymous SNPs (Table S4) were present in the pangenome of the 20 most common clone types, confirming that the pangenome SNPs are widespread in the global population and are unrelated to any habitat or modes of antimicrobial chemotherapy. Of the 509 nonsynonymous SNPs, 150 SNPs were identified in more than five P. aeruginosa CF isolates, implying that these SNPs spread by horizontal transfer. A nonrandom distribution of SNPs was also seen among the rare variants identified in five or fewer isolates. Compared to a Poisson distribution of random mutation, singular mutations were underrep- resented and doublets, triplets, etc., were overrepresented in the CF strain collection (P Ͻ 10 Ϫ5 ), demonstrating that the rare sequence variants in the antimicrobial susceptibility loci are under strong purifying selection. The observed amino acid changes either are harmless or contribute to immune evasion, improved fitness, drug resistance, or combinations thereof in the CF airways. Different SNP patterns in P. aeruginosa isolates from the initial and the chronic stages of infection support the idea that the adaptation to the CF lung habitat and the regular antipseudomonal chemotherapy are major drivers for the emergence of amino acid sequence variants. Eighteen strains in our data set had been collected during the first year of CF lung colonization. These strains carried widespread polymorphisms only in the antimicrobial susceptibility loci and were devoid of any of the 418 SNPs found in other CF isolates (P ϭ 10 Ϫ30 by Fisher's exact test), consistent with the interpretation that in the majority of cases, these SNPs had emerged during the chronic stage of CF lung infection.
Coding variants in AMR loci. The 17 antimicrobial resistance (AMR) loci affect (i) replication, transcription, and translation, (ii) cell wall biosynthesis, or (iii) membrane transport and its regulation (Fig. 4) .
(i) Replication, transcription, and translation. The DNA gyrase is the target of fluoroquinolones that are applied for oral antipseudomonal chemotherapy. The investigated P. aeruginosa CF strain panel carried 30 different coding variants (see Table S4 in the supplemental material). Twenty-four amino acid substitutions clustered in the N-terminal domain of the gyrase, including 10 mutations in the quinolone resistance-determining region (12, 13, (32) (33) (34) (35) . rpoB encodes the beta subunit of the DNA-dependent RNA polymerase. Most mutations were found in domains 2 and 6 of the enzyme, which are responsible for the maintenance of the open complex and for RNA binding and catalysis, respectively (36) (37) (38) . The fusA1 and fusA2 genes code for the highly homologous elongation factors EF-G1a and EF-G1b, which mediate translocation along the mRNA during translation (14, 39, 40) . Twenty-two of 52 amino acid substitutions in EF-G1a and 11 of 24 amino acid substitutions in EF-G1b resided in the catalytically active GTP binding domain (40) .
(ii) Cell wall biosynthesis. Mutations in ampD are the most frequently reported cause of ␤-lactam resistance in P. aeruginosa clinical isolates (16, 41) . The N-acetyl-anhydromuramyl-L-ala- nine-amidase AmpD is responsible for the uptake and recycling of muropeptides and negatively controls the ␤-lactamase AmpC (16) . We assigned the 29 amino acid substitutions which had been detected in the P. aeruginosa ampD genes to the known threedimensional structure of the Citrobacter freundii ortholog (42) (Fig. 5) . Fifteen mutations affected either the substrate binding site or the two sequence motifs which critically stabilize protein conformation by salt bridges (42) . The lipid A deacylase PagL synthesizes pentaacylated lipid A structures in CF lungs that are not observed in P. aeruginosa isolates from acute infections and the environment (15) . Modifications of lipid A acylation are associated with resistance to antimicrobial peptides and evasion of the host innate immune response (43) . PagL was found to be a hot spot for singular amino acid sequence variants, supporting the habitat-specific role of lipid A modifications in CF ( Fig. 3 ; see Table S4 in the supplemental material).
(iii) Membrane transport and its regulation. The modulation of uptake and efflux is a key mechanism of bacterial resistance to antimicrobials. We examined our international CF strain panel for mutations in transport systems that had displayed elevated mutation rates in our collection of serial isolates from a single CF clinic.
The proteins SpuE and SpuF are part of the polyamine uptake system (17) . More than 90% of the identified amino acid sequence variants were not present in our pangenome reference, suggesting that SpuE and SpuF, like PagL diversify preferentially in CF lungs (see Table S4 in the supplemental material).
ParR/ParS and AmgR/AmgS are two-component systems involved in the generation of antimicrobial resistance. ParR/ParS confers resistance to aminoglycosides and polymyxins by the regulation of the expression of RND efflux and lipopolysaccharide (LPS)-modifying operons (19, 44, 45) . Forty-eight of the 57 amino acid substitutions were novel and had not been observed in the reference, indicating that exposure to CF airways and antimicrobials is associated with diversifying selection of ParRS protein variants. One of the targets of ParR/ParS is MexS (45) . Within the context of multidrug resistance, MexS activates the expression of the mexXY efflux genes and downregulates the expression of the oprD porin (45, 46) . As observed for ParR/ParS, most protein variants of MexS are yet undescribed. AmgR/AmgS is a surveillance system that monitors membrane damages caused by aminoglycoside-induced protein misfolding and responds with indirect upregulation of the MexXY-OprM efflux pump (20, 21, 46) . Again, as seen for ParR/ParS and MexS, more than 80% of the nonsynonymous substitutions in AmgS were absent in the pangenome reference (see Table S4 in the supplemental material).
MexZ suppresses the expression of the MexXY-OprM efflux pump (47) , and correspondingly, if mexZ is inactivated, the multidrug transporter is constitutively overexpressed. Consistent with reports in the literature (48) , mexZ was the hot spot of mutation among the examined loci in our CF strain panel. Although mexZ has already been scanned for mutations in other collections of clinical isolates (18, (48) (49) (50) , 23 of the 30 amino acid changes were yet undescribed. When this panel of mutations was mapped onto the known three-dimensional structure of MexZ (51), three major clusters of mutations became evident (Fig. 6) . One stretch of mutations in the adjacent ␣1, ␣2, and ␣3 helices covered the DNA binding domain of the repressor. The second set of mutations affected five critical amino acids in close vicinity to the binding site. The third set targeted the C-terminal contact domain of dimer formation. All mutations affected functionally relevant residues and thus most likely are not neutral. The sequencing of serial P. aeruginosa isolates from CF airways had also identified elevated mutation rates in pumps and porins that are known for their global role in multidrug resistance, i.e., the porin OprD and components of the RND efflux pumps MexXY-OprM and MexAB-OprM (22, 52) . Our analysis of the international CF strain panel confirmed the expected rate of high sequence diversity.
MexA is the periplasmic adaptor protein which links MexB in the inner membrane with the porin OprM in the outer membrane (53) . All identified amino acid variants were not present in the pangenome reference, which indicates a driving role of antimicrobial chemotherapy and the CF habitat for the generation of mutants, the majority of which were detected in just one isolate. The mutations had targeted the three domains of the protein, i.e., the alpha-helical hairpin, the beta subunit, and the lipoyl domain, with similar frequencies (53) .
MexY constitutes the inner membrane drug/H ϩ antiporter of the MexXY-OprM efflux pump (18, 22, 54) . The normalized mutation spectrum was similar for MexA and MexY (Fig. 3) , but in contrast to the case for MexA, the singular sequence variants were less frequent in MexY (see Table S3 in the supplemental material). The amino acid variants were rather evenly distributed along the 1,046-amino-acid protein sequence. Eleven mutations affected the transmembrane domains 1, 3, 4, 5, 9, 11, and 12, 19 mutations were assigned to the cytoplasmic space, and 37 mutations were located in the periplasm, of which 13 and 20 amino acid variants were located in the large periplasmic loops L1/2 and L7/8, respectively (55) . None of the functionally characterized mutations were present in our strain panel (54, 56, 57) .
OprM forms the outer membrane channel for both tripartite pumps MexXY-OprM and MexAB-OprM (58, 59) . The sequence diversity among the CF isolates was comparably low (Fig. 3) . No coding variants were detected in the membrane-spanning beta barrel. The mostly conservative amino acid exchanges (see Table  S4 in the supplemental material) occurred in the N-terminal stretch and alpha-helices 1, 3, 7, and 8 (59) . In other words, OprM was distinct from the other targets by the lack of mutations in functionally relevant domains, i.e., the pore, and by the predominance of neutral or even benign amino acid exchanges with a high Dayhoff index.
The carboxylate transport channel OprD (OccD) (60, 61) is the entry portal for antipseudomonal carbapenems (31, 52) . The sequence analysis of the oprD genes uncovered spectrum of sequence variation other than that seen for all other targets. oprD showed the second-highest substitution rate, but singular nonsynonymous mutations were rare. Protein polymorphisms were frequent and widespread in the P. aeruginosa population as indicated by their presence in the pangenome reference (see Table S4 in the supplemental material) (24) . The yet-undescribed mutations found in the CF strain panel did not affect any obligatorily conserved residue, such as the basic amino acids in the barrel wall which are thought to guide substrate through the pore (61). Drastic amino acid changes at functionally relevant positions were apparently not tolerated by P. aeruginosa in the CF airways.
Stop mutations. The emergence of a premature termination codon will result in most cases in the loss of protein function, unless some translational read-through is promoted. The sequencing of an individual 6-to 7-Mbp large P. aeruginosa genome will typically identify one or two stop mutations (24, 27) . Amplicon sequencing of the 361 CF isolates in the 17 loci uncovered a significantly higher rate of stop mutations. In total, 69 stop mutations were detected in the 9.7 Mbp of sequenced DNA. Twentythree codons in eight genes were altered to a termination codon (Table 2) . Fourteen mutations (61%) were observed only once. Two stop mutations, Y238* in fusA2 and Q424* in oprD, were frequent and were seen in 15 and 16 independent isolates, respectively. mexA, mexZ, and pagL were most frequently affected by independent mutations, suggesting that the generation of a premature stop codon in this locus is beneficial for P. aeruginosa to survive in the CF lung habitat. If translated, most truncated proteins will probably be inactive or severely reduced in function; however, in the case of the four mexZ mutations in the C-terminal domain, only the formation of dimers may no longer be possible.
Considering their role in the CF lungs, the inactivation of pagL and mexZ in CF isolates was not unexpected. The loss of PagLmediated deacylation of lipid A is common in chronically colonized CF lungs with severe structural damage (15) , and the loss of the repressor MexZ will lead to the constitutive overexpression of the MexXY-OprM multidrug transporter, which actively expels antibiotics (47) . Loss-of-function mutations in mexA are less plausible for P. aeruginosa bacteria that are regularly exposed to antipseudomonal drugs. MexA is essential for the assembly of the MexAB-OprM efflux pump and for in vivo transport (62) . The identified premature termination codons reside in helix 2 or the disordered C-terminal domain (63) . Truncations in helix 2 should result in nonfunctional proteins, but truncations of the C-terminal end could result in functional protein variants that affect the architecture of the tripartite efflux pump and modify the OprM-mediated stimulation of the MexB pump (62) . Fourteen of the 23 nonsense mutations affected a glutamine codon. Compared to the spectrum of disease-causing stop mutations in the CFTR gene of the CF host (64) , this overrepresentation is highly unusual (P ϭ 1.6 ϫ 10 Ϫ4 ). We are unaware of any report in the literature of such a strong bias toward C-to-T transitions at the first position of the glutamine codon among nonsense mutations in P. aeruginosa (see Table S3 in the supplemental material).
Conclusion. Amplicon sequencing of the international CF strain panel has identified more than 1,900 SNPs in the 17 target loci. The genes had been selected on the basis of the sequence analysis of serial isolates from CF patients followed at a single center. This study on independent isolates from more than 250 patients seen at 30 CF centers in Europe confirms our hypothesis that the chosen loci are hot spots of mutations in CF lungs. The highest relative proportions of SNPs that are absent in the pangenome reference were found in fusA1A2, mexA, and pagL (see Table S4 in the supplemental material). These genes encode proteins that are involved in unrelated activities, i.e., translation, transport, and LPS modification, respectively, suggesting that P. aeruginosa orchestrates a diverse armory to survive in a hostile environment of host defense mechanisms and antimicrobial treatment. The CF lung habitat seems to favor diversifying selection in these targets of antimicrobial susceptibility and resistance. The mutation rate is elevated, about half of the singular SNPs are nonsynonymous, and the percentage of nonneutral amino acid exchanges is high. Our molecular epidemiology data point to an eminent role of private and de novo mutations in how the P. aeruginosa populations in individual CF lungs try to escape antimicrobial pressure.
